This program is: Prescription-only Clinician-led Medically supervised Focused on appetite regulation and sustainable weight management This program is not: A cosmetic or wellness treatment A rapid or guaranteed weight loss solution Suitable without medical assessment A replacement for healthy lifestyle practices Results vary between individuals and depend on medical suitability, adherence to clinical guidance, and lifestyle factors
For physique athletes and performance-driven individuals, this SIRT1 pathway activation means more fat burned, more muscle spared, and a higher energy ceiling during both cutting and maintenance phases
Ongoing guidance ensures patients transition from pharmacological support to self-sustaining behaviours
Research across various countries and healthcare settings has consistently shown that both SGLT-2 inhibitors and GLP-1 receptor agonists are underused, particularly in socioeconomically disadvantaged populations and minority groups, even though these populations often face a higher CVD burden and could potentially benefit the most from these treatments [4749]
El-Sayed AFM (ed) (2006) Tilapia culture
